Related Experiment Video
Updated: Jul 31, 2026

Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
Cobra cardiotoxin and phospholipase A2 as GAG-binding toxins: on the path from structure to cardiotoxicity and
1Department of Life Sciences, National Tsing Hua University, Hsinchu, Taiwan 30043.
Abstract:
Glycosaminoglycans (GAGs) represent the sulfated carbohydrate moieties of proteoglycans which occur abundantly in tissues of the cardiovascular system. Many proteins bind specifically to GAGs and perform an important role in inflammation, cell proliferation, and blood coagulation processes. Recently, in vitro GAG-binding studies of cardiotoxins (CTXs) and basic phospholipase A(2) (PLA(2)) from cobra venom established the toxins as two new families of GAG-binding proteins. In particular, discontinuous basic residues in beta-sheet CTXs may form a cationic cradle suitable for heparin binding, as in the case of fibronectin module III-13. The binding specificity of beta-sheet proteins to different GAGs can be further enhanced by involving other cationic clusters near the flexible loop of the molecule. Since the three-dimensional structures of many CTXs and PLA(2) are available, these two toxins may serve as models for the elucidation of the molecular recognition of GAG-binding proteins and also as polypeptide templates for further improvement of the binding specificity suitable for future biomedical application. Research along the line of GAG-guided toxicity of cobra venom components may help us to understand the functional role of GAGs and the action mechanism of cobra venom components in the cardiovascular system.
Insights
Cobra venom toxins, cardiotoxins (CTXs) and phospholipase A2 (PLA2), bind to glycosaminoglycans (GAGs). Their structures offer models for understanding GAG-binding proteins and developing biomedical applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Glycosaminoglycans (GAGs) are crucial in cardiovascular tissues, mediating inflammation, cell proliferation, and coagulation.
- Proteoglycans, containing GAGs, play vital roles in biological processes.
Purpose of the Study:
- To identify and characterize new GAG-binding proteins from cobra venom.
- To explore the structural basis of GAG-protein interactions for potential biomedical uses.
Main Methods:
- In vitro binding studies of cardiotoxins (CTXs) and basic phospholipase A2 (PLA2) with various GAGs.
- Analysis of the three-dimensional structures of CTXs and PLA2 to identify GAG-binding motifs.
Main Results:
- CTXs and PLA2 were identified as novel families of GAG-binding proteins.
- Discontinuous basic residues in beta-sheet CTXs form a 'cationic cradle' for heparin binding.
- Additional cationic clusters can enhance binding specificity to different GAGs.
Conclusions:
- Cobra venom toxins serve as valuable models for studying GAG-protein molecular recognition.
- These toxins can be utilized as polypeptide templates to engineer enhanced GAG-binding specificity for biomedical applications.
- Understanding GAG-guided venom toxicity elucidates GAG functions and venom mechanisms in the cardiovascular system.
More Related Videos
Related Concept Videos
GPCR Desensitization
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
IP3/DAG Signaling Pathway
Bacterial Toxins
Diphtheria

